The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) is a global medical device company focused on contact lenses and women's healthcare. It operates through two segments: CooperVision, which manufactures and sells a wide range of contact lenses including daily disposables, toric, multifocal, and orthokeratology lenses; and CooperSurgical, which provides medical devices, fertility solutions, and diagnostics for women's health. The company is headquartered in San Ramon, California, and has manufacturing and distribution facilities worldwide.

CooperVision generates the majority of revenue from contact lens sales, with a strong emphasis on silicone hydrogel and daily disposable lenses. CooperSurgical contributes through surgical instruments, fertility products (e.g., IVF media), and diagnostic tests. Revenue is diversified across geographic regions, with the Americas, Europe, and Asia-Pacific being key markets. The company's business model relies on innovation, brand reputation, and relationships with eye care professionals and healthcare providers.

The company operates in the Medical Instruments & Supplies industry within the Healthcare sector. It competes with other contact lens giants like Johnson & Johnson Vision, Alcon, and Bausch + Lomb, as well as women's health device firms. Cooper's competitive positioning is strengthened by its focus on specialty lenses (e.g., toric and multifocal) and its strong presence in the fast-growing daily disposable segment. Its financial metrics show solid profitability with a gross margin of 65.54% and operating margin of 16.69%.

Cooper's primary customers are eye care professionals (optometrists, ophthalmologists) who prescribe contact lenses to end consumers, and healthcare providers (hospitals, clinics) for surgical and fertility products. The target audience includes contact lens wearers seeking comfort and vision correction, and women requiring fertility treatments or surgical interventions. Key geographic markets are the United States, Europe, and Asia, with emerging markets contributing to growth. The company's recent revenue growth of 6.16% YoY and earnings growth of 25.41% YoY reflect its strong market position.

An auto-generated descriptive profile based on company data, for informational purposes only.